Farhan Fancy
Master’s student in the Institute of Medical Science at the University of Toronto
Data updated
Papers
Trials
Research Footprint
Farhan Fancy appears in 5 tracked papers (2021–2023), most studied alongside Ketamine and Psilocybin, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.
Most-cited paper: Psilocybin-assisted therapy for depression: A systematic review and meta-analysis (112 citations).
Frequent co-authors: Roger McIntyre, Jonathan Rosenblat and Joseph Vincenzo.
Background & Research
Farhan Fancy is a researcher at the University of Toronto’s Institute of Medical Science and the University Health Network’s Mood Disorders Psychopharmacology Unit. His published work has focused on ketamine and psilocybin interventions for depression, including systematic reviews and observational real-world effectiveness studies. UHN’s 2022 impact report describes him as a second-year Master’s student supervised by Joshua Rosenblat, studying the therapeutic uses of ketamine for bipolar depression.
Key Impact
Co-author on multiple ketamine and psilocybin systematic reviews and real-world ketamine effectiveness studies in depression and bipolar depression.
Collaboration Network
14 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Farhan Fancy is associated with.